Top compounds associated with response to IRX4


Feature Type Standardized
Nominal ANOVA
mRNA PX-12 CTRPv2 pan-cancer AAC -0.05 0.1
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.057 0.1
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.064 0.1
mRNA LY317615 GDSC1000 pan-cancer AAC 0.061 0.1
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.059 0.1
mRNA GSK1059615 CTRPv2 pan-cancer AAC -0.078 0.1
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.1
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.12 0.1
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.059 0.1
Download CSV